Nattawat Klomjit is a Nephrology physician affiliated with University of Minnesota. OpenAlex indexes 77 publications with 1,054 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 1st St SW
Rochester, MN 559050001
Telephone
507-284-2511Provider last certified this registry record 1 Sept 2021.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Travere Therapeutics, Inc.Program year202515 payments
- Calliditas Therapeutics US Inc.Program year20251 payment
- Alexion Pharmaceuticals, Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
74.2%Loop diuretic17.5%Furosemide52%Torsemide41%Bumetanide8%Part D<11 patientsCalcium channel blocker14.2%Amlodipine Besylate100%Part D≥40 patients+ 10 more classes in this area
Metabolism & gastrointestinal
23.4%SGLT2 inhibitor9.5%Jardiance81%Farxiga19%Part D<11 patientsCorticosteroid4.3%Prednisone100%Part D<11 patients+ 5 more classes in this area
Cancer & immunology
1.3%Complement 5a Receptor Antagonist1.3%Tavneos100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Successful treatment of resistant hypertension secondary to catecholamine-secreting glomus tumor
American Journal of Hypertension
2026 - WCN26-7065 CLINICAL CHARACTERISTICS AND OUTCOMES IN CANCER-ASSOCIATED TMA
Kidney International Reports
2026 - Parameters Associated With Renal Recovery and Survival in Myeloma Patients With Acute Renal Failure to Cast Nephropathy
American Journal of Hematology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Vicki Morrison, MD
University of Minnesota
Maria Hordinsky, MD
University of Minnesota
Paul Tuite, MD
University of Minnesota
Allyson Hart, MD
University of Minnesota
Andrew Levey, MD
Tufts Medical Center
Bertram Kasiske, MD
Hennepin Healthcare
Garabed Eknoyan, MD
Baylor College of Medicine
Lawrence Hunsicker, MD
University of Iowa
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”